Asparium L-Asparaginase Injection 10000 IU is a prescription oncology medicine identified as containing L-Asparaginase 10000 International Units (IU).

L-Asparaginase is an antineoplastic enzyme used as a component of selected combination chemotherapy regimens for acute lymphoblastic leukemia (ALL).

It works by breaking down the amino acid asparagine in the bloodstream. Certain leukemia cells have a limited ability to produce sufficient asparagine and may therefore be particularly susceptible to its depletion.

L-Asparaginase is an established medicine in selected leukemia treatment protocols, including pediatric and adult ALL regimens.

The stated 10000 IU strength represents enzyme activity and does not establish the dose required for an individual patient.

The exact enzyme source, formulation, manufacturer, administration route, packaging and approved indications of Asparium must be verified from its approved Indian product documentation.

Marketed by Essentials Emporium Enterprises, Asparium is listed within the oncology pharmaceutical category for hospitals, cancer treatment centres and authorized pharmaceutical buyers.

Key Product Features